Evaluation of alpha 1-antitrypsin, protein carbonyl and carboxy-Hb in COPD patients

V. Vijay, Asha Kamath, Vivian D'souza, M. Nandini*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic obstructive pulmonary disease (COPD) is one among the common lung diseases, caused by cigarette smoking. The increased risk of developing emphysema among smokers is suggested to result from a decrease in alpha 1 antitrypsin (a1-AT). Evaluation of a1-AT activity, protein carbonyl and carboxy-Hb levels, which contribute to the disease process in COPD patients, is the main aim of the study. Study group included 30 male COPD patients aged 45-65 years with history of COPD > 5yrs and tobacco smoking > 20yrs. Control group included 25 normal healthy individuals of the same age group. A decrease in a1-AT (p < 0.000) and increase in protein carbonyl (p < 0.000) with no significant change in carboxy-Hb levels was observed. The findings of the study strongly suggest that oxidative stress plays a key role in the disease process of COPD. Evaluation of protein carbonyl along with a1-AT aids in assessing the severity of the disease.

Original languageEnglish
Pages (from-to)69-71
Number of pages3
JournalBiomedicine (India)
Volume29
Issue number1
Publication statusPublished - 01-2009

All Science Journal Classification (ASJC) codes

  • General Biochemistry,Genetics and Molecular Biology
  • General Medicine

Fingerprint

Dive into the research topics of 'Evaluation of alpha 1-antitrypsin, protein carbonyl and carboxy-Hb in COPD patients'. Together they form a unique fingerprint.

Cite this